Issues in opioid management

American Journal of Physical Medicine and Rehabilitation

Volumn 84, Issue 3 SUPPL., 2005, Pages

  Bloodworth, Donna ^a,b  

^a Quentin Mease Hospital   (United States)

^b NONE   (United States)

Author keywords

Adverse Effects; Arthritis Pain; Chronic Nonmalignant Pain; Effects on Function; Opioids; Patient Attitudes; Patient Treatment Agreements; Perioperative Use; Physician Attitudes; Prescribing Habits; Randomized Controlled Trials

Indexed keywords

BENZATROPINE; BUTORPHANOL; CLONIDINE; CODEINE; DEXTROPROPOXYPHENE NAPSILATE; DEXTROPROPOXYPHENE PLUS PARACETAMOL; DIAMORPHINE; DIHYDROCODEINE; FENTANYL; HYDROCODONE; IBUPROFEN; MORPHINE; MORPHINE SULFATE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; PARACETAMOL; SUPROFEN; TRAMADOL;

ANXIETY DISORDER; ARTHRITIS; CANCER PAIN; CHRONIC PAIN; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISABILITY; DIZZINESS; DRUG ABUSE; DRUG DEPENDENCE; DRUG EFFICACY; DRUG SAFETY; DRUG USE; HEADACHE; HOT FLUSH; HUMAN; HYPERPYREXIA; HYPERTENSION; INSOMNIA; MEDICAL DECISION MAKING; MYDRIASIS; NAUSEA; PATIENT ATTITUDE; PATIENT COMPLIANCE; PERIOPERATIVE PERIOD; PHYSICIAN ATTITUDE; PRESCRIPTION; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION; REVIEW; RHINORRHEA; SEDATION; SIDE EFFECT; SYSTEMATIC REVIEW; TACHYCARDIA; TACHYPNEA; TREMOR; VOMITING; WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; ARTHRITIS; ATTITUDE TO HEALTH; CHRONIC DISEASE; HUMANS; OPIOID-RELATED DISORDERS; PAIN; PAIN, POSTOPERATIVE; PHYSICIAN'S PRACTICE PATTERNS; PSYCHOMOTOR PERFORMANCE; TREATMENT OUTCOME; UNITED STATES;

EID: 13844289467     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PHM.0000154907.30010.1B     Document Type: Review

References (83)

1. Musto DF: Iatrogenic addiction: The problem, its definition and history. Bull N Y Acad Med 1985;61:694-705
2. Loeser JD: Pain due to nerve injury. Spine 1985;10:232-5
3. Amir R, Liu CN, Kocsis JD, et al: Oscillatory mechanism in primary sensory neurones. Brain 2002;125(pt 2):421-35
4. Rang HP, Bevan S, Dray A: Chemical activation of nociceptive peripheral neurones. Br Med Bull 1991;47:534-48
5. Ollat H, Cesaro P: Pharmacology of neuropathic pain. Clin Neuropharmacol 1995;18:391-404
6. Iadarola MJ, Brady LS, Draisci G, et al: Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: Stimulus specificity, behavioral parameters and opioid receptor binding. Pain 1988;35:313-26
7. Woolf CJ: Generation of acute pain: Central mechanisms. Br Med Bull 1991;47:523-33
8. Oaklander AL: Shingles, postherpetic neuralgia, and postherpetic itch. Internat J Pain Med Palliat Care 2002;2:2-10
9. Thomson PDR: Tylenol, in: Physician's Desk Reference. Montvale, NJ, Thomson PDR, 2004
10. Turk DC, Brody MC, Okifuji EA: Physicians' attitudes and practices regarding the long-term prescribing of opioids for non-cancer pain. Pain 1994;59:201-8
11. de Craen AJ, Lampe-Schoenmaeckers AJ, Kraal JW, et al: Impact of experimentally-induced expectancy on the analgesic efficacy of tramadol in chronic pain patients: A 2 x 2 factorial, randomized, placebo-controlled, double-blind trial. J Pain Symptom Manage 2001;21:210-7
12. Messick RT: Evaluation of acetaminophen, propoxyphene, and their combination in office practice. J Clin Pharmacol 1979;19:227-30
13. Maier C, Hildebrandt J, Klinger R, et al: Morphine responsiveness, efficacy and tolerability in patients with chronic non-tumor associated pain: Results of a double-blind placebo-controlled trial. MONTAS Study Group. Pain 2002;97:223-33
14. Arkinstall W, Sandler A, Goughnour B, et al: Efficacy of controlled-release codeine in chronic non-malignant pain: A randomized, placebo-controlled clinical trial. Pain 1995;62:169-78
15. Sheather-Reid RB, Cohen M: Efficacy of analgesics in chronic pain: A series of N-of-1 studies. J Pain Symptom Manage 1998;15:244-52
16. Caldwell JR, Rapoport RJ, Davis JC, et al: Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: Results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial. J Pain Symptom Manage 2002;23:278-91
17. Peloso PM, Bellamy N, Bensen W, et al: Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee. J Rheumatol 2000;27:764-71
18. Roth SH, Fleischmann RM, Burch FX, et al: Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: Placebo-controlled trial and long-term evaluation. Arch Intern Med 2000;160:853-60
19. Muller FO, Odendaal CL, Muller FR, et al: Comparison of the efficacy and tolerability of a paracetamol/codeine fixed-dose combination with tramadol in patients with refractory chronic back pain. Arzneimittelforschung 1998;48:675-9
20. Mullican WS, Lacy JR: Tramadol/acetaminophen combination tablets and codeine/acetaminophen combination capsules for the management of chronic pain: A comparative trial. TRAMAP-ANAG-006 Study Group. Clin Ther 2001;23:1429-45
21. Palangio M, Damask MJ, Morris E, et al: Combination hydrocodone and ibuprofen versus combination codeine and acetaminophen for the treatment of chronic pain. Clin Ther 2000;22:879-92
22. Moulin DE, Iezzi A, Amireh R, et al: Randomised trial of oral morphine for chronic non-cancer pain. Lancet. 1996;347:143-7
23. Kjaersgaard-Andersen P, Nafei A, Skov O, et al: Codeine plus paracetamol versus paracetamol in longer-term treatment of chronic pain due to osteoarthritis of the hip: A randomised, double-blind, multi-centre study. Pain 1990;43:309-18
24. Salzman RT, Brobyn RD: Long-term comparison of suprofen and propoxyphene in patients with osteoarthritis. Pharmacology 1983;27(suppl 1):55-64
25. Lloyd RS, Costello F, Eves MJ, et al: The efficacy and tolerability of controlled-release dihydrocodeine tablets and combination dextropropoxyphene/ paracetamol tablets in patients with severe osteoarthritis of the hips. Curr Med Res Opin 1992;13:37-48
26. Wilder-Smith CH, Hill L, Spargo K, et al: Treatment of severe pain from osteoarthritis with slow-release tramadol or dihydrocodeine in combination with NSAID's: A randomised study comparing analgesia, antinociception and gastrointestinal effects. Pain 2001;91:23-31
27. Jamison RN, Raymond SA, Slawsby EA, et al: Opioid therapy for chronic noncancer back pain: A randomized prospective study. Spine 1998;23:2591-600
28. Allan L, Hays H, Jensen NH, et al: Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ 2001;322:1154-8
29. Rangel-Guerra R: An open evaluation of oral butorphanol as long-term therapy in out-patients suffering from moderate to severe chronic pain. J Int Med Res 1981;9:120-3
30. Milligan K, Lanteri-Minet M, Borchert K, et al: Evaluation of long-term efficacy and safety of transdermal fentanyl in the treatment of chronic noncancer pain. J Pain 2001;2:197-204
31. Ytterberg SR, Mahowald ML, Woods SR: Codeine and oxycodone use in patients with chronic rheumatic disease pain. Arthritis Rheum 1998;41:1603-12
32. Portenoy RK, Foley KM: Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases. Pain 1986;25:171-86
33. Jamison RN, Anderson KO, Peeters-Asdourian C, et al: Survey of opioid use in chronic nonmalignant pain patients. Reg Anesth 1994;19:225-30
34. Zenz M, Strumpf M, Tryba M: Long-term oral opioid therapy in patients with chronic nonmalignant pain. J Pain Symptom Manage 1992;7:69-77
35. Maruta T, Swanson DW: Problems with the use of oxycodone compound in patients with chronic pain. Pain 1981;11:389-96
36. Cowan DT, Allan L, Griffiths P: A pilot study into the problematic use of opioid analgesics in chronic non-cancer pain patients. Int J Nurs Stud 2002;39:59-69
37. Ballantyne JC, Mao J: Opioid therapy for chronic pain. N Engl J Med 2003;349:1943-53
38. Farrar JT, Young JP Jr, LaMoreaux L, et al: Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001;94:149-58
39. Jensen MP: The validity and reliability of pain measures in adults with cancer. J Pain 2003;4:2-21
40. McWilliams LA, Cox BJ, Enns MW: Mood and anxiety disorders associated with chronic pain: An examination in a nationally representative sample. Pain 2003;106:127-33
41. Mossey JM, Gallagher RM: The longitudinal occurrence and impact of comorbid chronic pain and chronic depression over two years in continuing care retirement community residents. Pain Med 2004;5:335-48
42. Covic T, Adamson B, Spencer D, et al: A biopsychosocial model of pain and depression in rheumatoid arthritis: A 12-month longitudinal study. Rheumatology (Oxford) 2003;42:1287-94
43. Lin EH, Katon W, Von Korff M, et al: Effect of improving depression care on pain and functional outcomes among older adults with arthritis: A randomized controlled trial. JAMA 2003;290:2428-9
44. Porter J, Jick H: Addiction rare in patients treated with narcotics. N Engl J Med 1980;302:123
45. Perry S, Heidrich G: Management of pain during debridement: A survey of U.S. burn units. Pain 1982;13:267-80
46. Medina JL, Diamond S: Drug dependency in patients with chronic headaches. Headache 1977;17:12-4
47. Menefee LA, Frank ED, Crerand C, et al: The effects of transdermal fentanyl on driving, cognitive performance, and balance in patients with chronic nonmalignant pain conditions. Pain Med 2004;5:42-9
48. Jamison RN, Schein JR, Vallow S, et al: Neuropsychological effects of long-term opioid use in chronic pain patients. J Pain Symptom Manage 2003;26:913-21
49. Cicala RS, Wright H: Outpatient treatment of patients with chronic pain: An analysis of cost savings. Clin J Pain 1989;5:223-6
50. Stieg RL, Turk DC: Chronic pain syndrome: The necessity of demonstrating the cost-benefit of treatment. Pain Manage 1988;5:53-8
51. Portenoy RK, Hagen NA: Breakthrough pain: Definition, prevalence and characteristics. Pain 1990;41:273-81
52. Fishman SM, Bandman TB, Edwards A, et al: The opioid contract in the management of chronic pain. J Pain Symptom Manage 1999;18:27-37
53. Fishman SM, Mahajan G, Jung SW, et al: The trilateral opioid contract: Bridging the pain clinic and the primary care physician through the opioid contract. J Pain Symptom Manage 2002;24:335-44
54. Schatzberg AF: The relationship of chronic pain and depression. J Clin Psychiatry 2004;65(suppl 12):3-4
55. Rapp SE, Ready LB, Nessly ML: Acute pain management in patients with prior opioid consumption: A case-controlled retrospective review. Pain 1995;61:195-201
56. de Leon-Casasola OA, Myers DP, Donaparthi S, et al: A comparison of postoperative epidural analgesia between patients with chronic cancer taking high doses of oral opioids versus opioid-naive patients. Anesth Analg 1993;76:302-7
57. Peacock JE, Wright BM, Withers MR, et al: Evaluation of a pilot regimen for postoperative pain control in patients receiving oral morphine pre-operatively. Anaesthesia 2000;55:1208-12
58. Bakris GL, Cross PD, Hammarsten JE: The use of clonidine for management of opiate abstinence in a chronic pain patient. Mayo Clin Proc 1982;57:657-60
59. Jimenez AC, Gusmorino P, Pinter I, et al: The use of clonidine for the treatment of meperidine withdrawal in a multidisciplinary pain program setting: A case presentation. Bull Hosp Jt Dis Orthop Inst 1987;47:72-7
60. Gerra G, Zaimovic A, Giusti F, et al: Lofexidine versus clonidine in rapid opiate detoxification. J Subst Abuse Treat 2001;21:11-7
61. Taschner KL: A controlled comparison of clonidine and doxepin in the treatment of the opiate withdrawal syndrome. Pharmacopsychiatry 1986;19:91-5
62. Washton AM, Resnick RB: Outpatient opiate detoxification with clonidine. J Clin Psychiatry 1982;43:39-41
63. Washton AM, Resnick RB: Clonidine in opiate withdrawal: Review and appraisal of clinical findings. Pharmacotherapy 1981;1:140-6
64. United States Department of Health and Human Services Substance Abuse and Mental Health Services Administration: Drug Addiction Treatment Act of 2000. Available at: http://buprenophine.samhsa.gov/data.html. Accessed November 10, 2004
65. Cohen S: Heroin, in: Encyclopedia Americana. Danbury, CT, Grolier Incorporated, 1985, vol 14, pp 149-50
66. Portenoy RK: Opioid therapy for chronic nonmalignant pain: A review of the critical issues. J Pain Symptom Manage 1996;11:203-17
67. Rayport M: Experience in the management of patients medically addicted to narcotics. J Am Med Assoc 1954;156:684-91
68. Sproule BA, Busto UE, Somer G, et al: Characteristics of dependent and nondependent regular users of codeine. J Clin Psychopharmacol 1999;19:367-72
69. Brown RL, Patterson JJ, Rounds LA, et al: Substance abuse among patients with chronic back pain. J Fam Pract 1996;43:152-60
70. Manila T, Swanson DW, Finlayson RE: Drug abuse and dependency in patients with chronic pain. Mayo Clin Proc 1979;54:241-4
71. Schofferman J: Long-term use of opioid analgesics for the treatment of chronic pain of nonmalignant origin. J Pain Symptom Manage 1993;8:279-88
72. Jamison RN: Comprehensive pretreatment and outcome assessment for chronic opioid therapy in nonmalignant pain. J Pain Symptom Manage 1996;11:231-41
73. Malaivijitnond S, Varavudhi P: Evidence for morphine-induced galactorrhea in male cynomolgus monkeys. J Med Primatol 1998;27:1-9
74. Mendelson JH, Mendelson JE, Patch VD: Plasma testosterone levels in heroin addiction and during methadone maintenance. J Pharmacol Exp Ther 1975;192:211-7
75. Mendelson JH, Meyer RE, Ellingboe J, et al: Effects of heroin and methadone on plasma cortisol and testosterone. J Pharmacol Exp Ther 1975;195:296-302
76. Rasheed A, Tareen IA: Effects of heroin on thyroid function, cortisol and testosterone level in addicts. Pol J Pharmacol 1995;47:441-4
77. Malik SA, Khan C, Jabbar A, et al: Heroin addiction and sex hormones in males. J Pak Med Assoc 1992;42:210-2
78. Abs R, Verhelst J, Maeyaert J, et al: Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab 2000;85:2215-22
79. Finch PM, Roberts LJ, Price L, et al: Hypogonadism in patients treated with intrathecal morphine. Clin J Pain 2000;16:251-4
80. Roy S, Loh HH: Effects of opioids on the immune system. Neurochem Res 1996;21:1375-86
81. Risdahl JM, Khanna KV, Peterson PK, et al: Opiates and infection. J Neuroimmunol 1998;83:4-18
82. Makman MH: Morphine receptors in immunocytes and neurons. Adv Neuroimmunol 1994;4:69-82
83. Rahim RT, Adler MW, Meissler JJ Jr, et al: Abrupt or precipitated withdrawal from morphine induces immunosuppression. J Neuroimmunol 2002;127:88-95